217 related articles for article (PubMed ID: 28433508)
1. Organs at risk in lung SBRT.
De Rose F; Franceschini D; Reggiori G; Stravato A; Navarria P; Ascolese AM; Tomatis S; Mancosu P; Scorsetti M
Phys Med; 2017 Dec; 44():131-138. PubMed ID: 28433508
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
4. Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy.
Pollom EL; Chin AL; Diehn M; Loo BW; Chang DT
Semin Radiat Oncol; 2017 Jul; 27(3):197-208. PubMed ID: 28577827
[TBL] [Abstract][Full Text] [Related]
5. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
[TBL] [Abstract][Full Text] [Related]
6. [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
Blais E; Pichon B; Mampuya A; Antoine M; Lagarde P; Kantor G; Breton-Callu C; Lefebvre C; Gerard M; Aamarcha A; Ozsahin M; Bourhis J; Maingon P; Troussier I; Pourel N
Cancer Radiother; 2017 Oct; 21(6-7):584-596. PubMed ID: 28886981
[TBL] [Abstract][Full Text] [Related]
7. Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer.
Videtic GMM; Reddy CA; Woody NM; Stephans KL
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):436-442. PubMed ID: 34048817
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy of central lung malignancies using a simultaneous integrated protection approach : A prospective observational study.
Mazzola R; Ruggieri R; Figlia V; Rigo M; Giaj Levra N; Ricchetti F; Nicosia L; Corradini S; Alongi F
Strahlenther Onkol; 2019 Aug; 195(8):719-724. PubMed ID: 30689026
[TBL] [Abstract][Full Text] [Related]
9. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?
Videtic GM; Stephans KL
Curr Oncol Rep; 2010 Jul; 12(4):235-41. PubMed ID: 20446066
[TBL] [Abstract][Full Text] [Related]
10. Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
Duijm M; van der Voort van Zyp NC; van de Vaart P; Oomen-de Hoop E; Mast ME; Hoogeman MS; Nuyttens JJ
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):73-81. PubMed ID: 31499137
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
Cozzi S; Alì E; Bardoscia L; Najafi M; Botti A; Blandino G; Giaccherini L; Ruggieri MP; Augugliaro M; Iori F; Sardaro A; Iotti C; Ciammella P
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681659
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
13. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
15. SBRT for centrally localized NSCLC - What is too central?
Roesch J; Panje C; Sterzing F; Mantel F; Nestle U; Andratschke N; Guckenberger M
Radiat Oncol; 2016 Dec; 11(1):157. PubMed ID: 27912764
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios.
Andruska N; Stowe HB; Crockett C; Liu W; Palma D; Faivre-Finn C; Badiyan SN;
J Thorac Oncol; 2021 Jul; 16(7):1075-1085. PubMed ID: 33901637
[TBL] [Abstract][Full Text] [Related]
17. Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
Kong FS; Moiseenko V; Zhao J; Milano MT; Li L; Rimner A; Das S; Li XA; Miften M; Liao Z; Martel M; Bentzen SM; Jackson A; Grimm J; Marks LB; Yorke E
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):172-187. PubMed ID: 30496880
[TBL] [Abstract][Full Text] [Related]
18. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
[TBL] [Abstract][Full Text] [Related]
19. Complications from Stereotactic Body Radiotherapy for Lung Cancer.
Kang KH; Okoye CC; Patel RB; Siva S; Biswas T; Ellis RJ; Yao M; Machtay M; Lo SS
Cancers (Basel); 2015 Jun; 7(2):981-1004. PubMed ID: 26083933
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
